Novel Femoral Artery Puncture Closure Device in Patients Undergoing Interventional and
Diagnostic Cardiac Procedures

The sizes of introducer sheaths and guiding catheters for percutaneous therapeutic interventions have decreased, which should reduce access-site complications.1–6 However, the use of novel antiplatelet drugs like glycoprotein IIb/IIIa inhibitors7,8 tends to increase access-site complications. The search for simple, safe and cost-effective devices for percutaneous puncture site closure is ongoing. Collagen plug devices were initial steps in this direction. They have been only moderately successful in reducing groin complications, especially in patients with aggressive anticoagulation.9–11 The only suture-based system currently available is quite cumbersome and inferior in terms of efficacy.12 In this study, we prospectively evaluated our initial experience with a new suture-mediated device (6 French X-PRESS device, X-SITE Medical, Blue Bell, Pennsylvania) and determined whether patients could be ambulated safely at 1 hour after both diagnostic and therapeutic interventions. METHODS The X-PRESS system consists of the X-PRESS device (6 French size), a guidewire, a suture pack containing a single strand of suture attached to two needles and a knot pusher (Figure 1). The X-PRESS device is composed of a sheath that is mounted to the distal end of a molded hub, which can be threaded over the guidewire (Figure 2). The hub incorporates a slit that allows two needles attached to a single strand of suture to be individually advanced across a tissue capture region and then back into the device (Figures 3 and 4). The device is withdrawn, leaving a suture loop across the arteriotomy site (Figure 5). A knot is prepared and then advanced using the knot pusher, thus tightening and securing the suture loop across the arteriotomy site. Hemostasis is thus achieved through a percutaneous surgical closure (Figure 6). Device deployment was performed after initial training on the use of the device provided by the manufacturer over a one-week period in the catheterization laboratory. All patients provided written informed consent. Patients received 5,000 U of heparin or less. Patients with > 6 French sheaths, on more than 5,000 U heparin, or on glycoprotein IIb/IIIa inhibitors were excluded. All patients were observed for groin complications during the hospital stay. No patient was discharged the same day in spite of the possibility to do so because the admission procedure of the hospital requires an overnight stay. Vascular ultrasound was performed in the first five patients and revealed no pseudoaneurysms. RESULTS The baseline characteristics of this study are summarized in Table 1. All patients had 6 French access sheaths. Procedures performed included 36 diagnostic interventions (73%) and 15 therapeutic interventions (27%). The devices were deployed immediately following the procedure. Once the sutures were secured, no additional manual pressure was used unless bleeding persisted. Following the procedure, a simple dressing was applied. Patients were ambulated after a period of 1.3 ± 0.4 hours of bedrest except for patients with failure to deploy and one with a minor hematoma. The device was successfully deployed in 48 patients (94%). Failure to deploy was observed in 3 patients (6%), of which 2 patients were among the initial patients treated. Failures were due to missing the tissue lip with the needle. All of these patients received manual compression without untoward sequelae. The average time to complete arterial hemostasis (TTH) was 5.5 ± 3.5 minutes (range, 3–26 minutes). Of the 48 successful device closures, a total of 44 patients (92%) attained immediate total hemostasis without the need for additional manual compression and had uneventful courses. Four patients (8%) needed additional manual compression for an average period of 10 minutes. Three patients had trivial oozing needing no further intervention. One patient developed a hematoma (Study limitations. The sample size of this initial feasibility trial is small. Randomized studies for comparisons with other hemostatic techniques and devices need to be carried out. Patients received minimal or no anticoagulation. The safety of the device in conjunction with such anticoagulation and antithrombotic therapy (including glycoprotein IIb/IIIa antagonists) needs to be tested in further studies. CONCLUSION Our initial experience with a novel suture-mediated device was promising. This device is an effective, safe and relatively cost-efficient tool for arterial hemostasis after percutaneous interventions. It affords early ambulation, short time to discharge, and little patient morbidity, which could have long-term cost implications. This device is a good alternative to the existing closure devices in the management of arterial access sites.

1. Wyman RM, Safian RD, Portway V, et al. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1988;12:1400–1406. 2. Bredlau CE, Roubin GS, Leimgruber PP, et al. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985;72:1044–1052. 3. Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569–1578. 4. Moscucci M, Mansour KA, Kent KC, et al. Peripheral vascular complications of directional coronary atherectomy and stenting: Predictors, management, and outcome. Am J Cardiol 1994;74:448–453. 5. Dorros G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: Report of complications from the National Heart, Lung and Blood Institute PTCA Registry. Circulation 1983;67:723–730. 6. Bogart DB, Bogart MA, Miller JT, et al. Femoral artery catheterization complications: A study of 503 consecutive patients. Cathet Cardiovasc Diagn 1995;34:8–13. 7. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689–1696. 8. Aguirre FV, Topol EJ, Ferguson JJ, et al. Bleeding complications with the chimeric antibody to platelet glycoprotein IIb/IIIa integrin in patients undergoing percutaneous coronary intervention. The EPIC Investigators. Circulation 1995;91:2882–2890. 9. Webb JG, Carere RA, Dodek AA. Collagen plug hemostatic closure of femoral arterial puncture sites following implantation of intracoronary stents. Cathet Cardiovasc Diagn 1993;30:314–316. 10. Foran JP, Patel D, Brookes J, Wainwright RJ. Early mobilisation after percutaneous cardiac catheterisation using collagen plus (VasoSeal) haemostasis. Br Heart J 1993;69:424–429. 11. Carere RG, Webb JG, Miyagishima R, et al. Groin complications associated with collagen plug closure of femoral arterial puncture sites in anticoagulated patients. Cathet Cardiovasc Diagn 1998;43:124–129. 12. Duffin DC, Muhlestein JB, Allisson SB, et al. Femoral arterial puncture management after percutaneous coronary procedures: A comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invas Cardiol 2001;13:354–362. 13. Lumsden AB, Miller JM, Kosinski AS, et al. A prospective evaluation of surgically treated groin complications following percutaneous cardiac procedures. Am J Surg 1994;60:132–137. 14. Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992;69:63–68. 15. Gerckens U, Cattelaens N, Lampe EG, Grube E. Management of arterial puncture site after catheterization procedures: Evaluating a suture-mediated closure device. Am J Cardiol 1999;83:1658–1663. 16. Kussmaul WG, Buchbinder M, Whitlow PL, et al. Femoral artery hemostasis using an implantable device (AngioSeal) after coronary angioplasty. Cathet Cardiovasc Diagn 1996;37:362–365. 17. Berge PG, Winter UJ, Hoffmann M, et al. Local vascular complications in heart catheters studies. Z Kardiol 1993;82:449–456. 18. Bach R, Espinola-Klein C, Ozbek C, et al. Complications after coronary angiography and balloon dilatation. Dtsch Med Wochenschr 1993;118:1669–1676. 19. Fransson SG, Nylander E. Vascular injury following cardiac catheterization, coronary angiography, and coronary angioplasty. Eur Heart J 1994;15:232–235. 20. Carere RG, Webb JG, Ahmed T, Dodek AA. Initial experience using Prostar: A new device for percutaneous suture-mediated closure of arterial puncture sites. Cathet Cardiovasc Diagn 1996;37:367–372. 21. Sridhar K, Fischman D, Goldberg S, et al. Peripheral vascular complications after intracoronary stent placement: Prevention by use of a pneumatic vascular compression device. Cathet Cardiovasc Diagn 1996;39:224–229.